Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Thomas Jefferson University
Research
Vaccine combo hits back at treatment-resistant cancer
An experimental vaccine combo is significantly more effective at fighting recurrent cancers in animal models than either approach by itself.
Gabrielle Masson
Jun 23, 2022 11:01am
Medtronic taps TikTok-famous doc as first-ever CMO of GI segment
Oct 22, 2021 9:55am
Treating multiple sclerosis with a cell therapy
Nov 4, 2020 2:00pm
Viracta's combo garners high response in EBV-linked lymphoma
Jun 3, 2019 11:39am
How melanoma resists BRAF inhibitors
Nov 7, 2018 8:58am
New protein could unravel the causes of some brain disorders
Jun 19, 2017 9:39am
